Category: Leonhart

Suit Before Ninth Circuit Court Of Appeals Seeks To Halt Federal Actions Against California’s Medical Cannabis Providers

On Wednesday, October 24, a group of California dispensary operators, medical cannabis providers, and patients, as Plaintiffs, filed their Opening Brief before the Ninth Circuit Court of Appeals in San Francisco, asking the Circuit Court to hold that Plaintiffs, in their continuing litigation against the Federal Government, have a constitutional Ninth Amendment and Substantive Due Process fundamental right to distribute, possess and use medical cannabis. The brief, filed by members of the NORML Legal Committee, also contends that the Federal Government’s criminal prohibition of medical cannabis has no rational basis […]

Appeals Court To Review DEA’s Dismissal Of Cannabis Rescheduling Petition

The U.S. Court of Appeals for the D.C. Circuit will hear opening arguments next week in a lawsuit challenging the federal government’s refusal to consider reclassifying cannabis as a schedule I prohibited substance under federal law. At issue in the case is whether the Drug Enforcement Administration (DEA) acted appropriately when the agency last year denied an administrative petition – initially filed by a coalition of public interest organizations, including NORML, in 2002 – that called on the agency to initiate hearings to reassess the present classification of cannabis. Under […]

Scientific Review: “There Is Now Clear Evidence That Cannabinoids Are Useful For The Treatment Of Various Medical Conditions”

For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law, which states that the plant and its organic constituents possess a “high potential for abuse,” and that they lack “accepted medical use” and “accepted safety … under medical supervision.” According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide “clear evidence that […]

Scientific Journal: Cannabis’ “Schedule I Classification Is Not Tenable”

The present classification of cannabis and its organic compounds as schedule I prohibited substances under federal law is scientifically indefensible, according to a just published review in The Open Neurology Journal. Investigators with the University of California at San Diego and the University of California, Davis reviewed the results of several recent clinical trials assessing the safety and efficacy of inhaled or vaporized cannabis. They concluded: “Evidence is accumulating that cannabinoids may be useful medicine for certain indications. Control of nausea and vomiting and the promotion of weight gain in […]

MUST WATCH: Rep. Jared Polis Destroys DEA Administrator During Congressional Hearing

Representative Jared Polis (D-CO) made some must watch reform video today when he grilled DEA Administrator, Michele Leonhart, over the relative health impacts of marijuana versus other drugs. Rep. Polis has been an outspoken advocate of marijuana legalization and was given the Rufus King, Sr. Award For Outstanding Public Leadership in the Field of MJ Law Reform at NORML’s 2011 Conference in Denver, at which he was also the keynote speaker. Click play below and watch pure drug war idiocy in action. Leonhart’s inability to answer simple questions would be […]

Federal Government Reaffirms ‘Flat Earth’ Position Regarding Medical Cannabis

Earlier today, United States DEA Administrator Michele Leonhart reaffirmed in the Federal Register the administration’s ‘flat Earth’ position regarding the medical properties of cannabis.
Responding to a nine-year-old petition to reclassify marijuana under federal law filed by a coalition of advocacy groups, including NORML and California NORML, Leonhart stated, “[T]here is no substantial evidence that marijuana […]